Related Experiment Video
Updated: Jul 7, 2026

09:19
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
Published on: July 14, 2022
3.3K
Cholangiocarcinoma
Matthew E Dixon1, Michael Williams1, Sam G Pappas2
1Division of Surgical Oncology, Department of Surgery, Rush University Medical Center, Chicago, IL, USA.
Cancer Treatment and Research
|August 30, 2024
Abstract:
Cholangiocarcinoma (CC) is a heterogeneous group of malignancies that originates at any point along the biliary tree. CC is an uncommon malignancy as it represents approximately 3% of all gastrointestinal malignancies, though its global incidence is rising. CC can often be asymptomatic in its early stages and as a result, it is frequently diagnosed in later stages, leading to challenges in clinical management.

